Company logo

FHTX - Foghorn Therapeutics Inc.

NASDAQ -> Healthcare -> Biotechnology
Cambridge, United States
Type: Equity

FHTX price evolution
FHTX
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $82.04 $72.01 $59.41 $52.35
Short term investments $153.72 $189.58 $226.61 $265.33
Net receivables
Inventory
Total current assets $240.18 $265.44 $290.49 $320.7
Long term investments
Property, plant & equipment $42.91 $45.14 $46.2 $48.11
Goodwill & intangible assets
Total noncurrent assets $45.73 $47.98 $49.08 $52.18
Total investments $153.72 $189.58 $226.61 $265.33
Total assets $285.92 $313.42 $339.58 $372.88
Current liabilities
Accounts payable $6.26 $6.5 $6.93 $7.29
Deferred revenue $302.67 $308.43 $325.91 $331.51
Short long term debt $8.52 $8.37 $7.67 $6.35
Total current liabilities $58.44 $52.01 $56.64 $55.8
Long term debt $36.55 $38.71 $40.27 $43.49
Total noncurrent liabilities $304.67 $318.8 $332.29 $341.67
Total debt $45.07 $47.08 $47.94 $49.84
Total liabilities $363.11 $370.81 $388.93 $397.47
Shareholders' equity
Retained earnings -$471.56 -$447.46 -$433.11 -$403.63
Other shareholder equity -$0.83 -$1.89 -$2.72 -$2.87
Total shareholder equity -$77.19 -$57.39 -$49.35 -$24.59
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $82.04 $53.92 $102.87 $94.53
Short term investments $153.72 $293.58 $53.15 $92.97
Net receivables $300
Inventory
Total current assets $240.18 $351.4 $459.56 $190.69
Long term investments
Property, plant & equipment $42.91 $49.4 $56.08 $62.33
Goodwill & intangible assets
Total noncurrent assets $45.73 $53.48 $60.21 $64.91
Total investments $153.72 $293.58 $53.15 $92.97
Total assets $285.92 $404.88 $519.77 $255.59
Current liabilities
Accounts payable $6.26 $5.41 $3.82 $3.68
Deferred revenue $302.67 $336.82 $351.05 $14.57
Short long term debt $8.52 $5.97 $6.99 $3.98
Total current liabilities $58.44 $55.2 $48.69 $18.85
Long term debt $36.55 $45.54 $51.34 $78.02
Total noncurrent liabilities $304.67 $349.57 $374.21 $90.56
Total debt $45.07 $51.51 $58.33 $82
Total liabilities $363.11 $404.77 $422.9 $109.41
Shareholders' equity
Retained earnings -$471.56 -$373.14 -$264.26 -$162.94
Other shareholder equity -$0.83 -$3.99 -$0.01 -$0.01
Total shareholder equity -$77.19 $0.11 $96.87 $146.19
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $5.77 $17.48 $5.6 $5.31
Cost of revenue
Gross Profit $5.77 $17.48 $5.6 $5.31
Operating activities
Research & development $24.2 $26.25 $29.25 $29.98
Selling, general & administrative $7.02 $8.31 $8.4 $8.64
Total operating expenses $31.23 $34.56 $37.65 $38.63
Operating income -$25.46 -$17.08 -$32.05 -$33.32
Income from continuing operations
EBIT -$22.12 -$13.61 -$28.55 -$29.93
Income tax expense $1.99 $0.74 $0.94 $0.56
Interest expense
Net income
Net income -$24.11 -$14.35 -$29.49 -$30.49
Income (for common shares) -$24.11 -$14.35 -$29.49 -$30.49
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $34.16 $19.23 $1.32 $0.43
Cost of revenue
Gross Profit $34.16 $19.23 $1.32 $0.43
Operating activities
Research & development $109.69 $105.62 $80.33 $57.72
Selling, general & administrative $32.37 $30.75 $21.73 $11.25
Total operating expenses $142.06 $136.37 $102.05 $68.96
Operating income -$107.91 -$117.14 -$100.73 -$68.53
Income from continuing operations
EBIT -$94.2 -$108.88 -$99.41 -$67.82
Income tax expense $4.23
Interest expense $1.91 $0.98
Net income
Net income -$98.43 -$108.88 -$101.32 -$68.8
Income (for common shares) -$98.43 -$108.88 -$101.32 -$68.8
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$24.11 -$14.35 -$29.49 -$30.49
Operating activities
Depreciation $2.25 $2.19 $2.17 $2.06
Business acquisitions & disposals
Stock-based compensation $3.05 $4.09 $4.47 $4.57
Total cash flows from operations -$27.54 -$27.21 -$32.17 -$31.18
Investing activities
Capital expenditures -$0.04 -$0.08 -$0.47 -$0.64
Investments $37.42 $38.51 $39.6 $30.14
Total cash flows from investing $37.38 $38.43 $39.13 $29.5
Financing activities
Dividends paid
Sale and purchase of stock $0.19 $1.39 $0.1 $0.1
Net borrowings
Total cash flows from financing $0.19 $1.39 $0.1 $0.1
Effect of exchange rate
Change in cash and equivalents $10.03 $12.6 $7.06 -$1.57
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$98.43 -$108.88 -$101.32 -$68.8
Operating activities
Depreciation $8.66 $7.9 $7.51 $5.53
Business acquisitions & disposals
Stock-based compensation $16.19 $14.34 $8.38 $2.96
Total cash flows from operations -$118.11 $193.61 -$50.25 -$31.29
Investing activities
Capital expenditures -$1.22 -$1.21 -$3.31 -$15.93
Investments $145.67 -$243.11 $39.49 -$92.98
Total cash flows from investing $144.45 -$244.32 $36.17 -$108.91
Financing activities
Dividends paid
Sale and purchase of stock $1.78 $1.76 $43.62 $123.34
Net borrowings -$21.2 $4.27
Total cash flows from financing $1.78 $1.76 $22.42 $217.47
Effect of exchange rate
Change in cash and equivalents $28.12 -$48.95 $8.34 $77.27
Fundamentals
Market cap $283.71M
Enterprise value $246.74M
Shares outstanding 42.28M
Revenue $34.16M
EBITDA -$85.54M
EBIT -$94.20M
Net Income -$98.43M
Revenue Q/Q 37.88%
Revenue Y/Y 77.63%
P/E ratio -2.88
EV/Sales 7.22
EV/EBITDA -2.88
EV/EBIT -2.62
P/S ratio 8.31
P/B ratio -3.72
Book/Share -1.81
Cash/Share 1.94
EPS -$2.33
ROA -30.01%
ROE 188.81%
Debt/Equity -4.70
Net debt/EBITDA -3.29
Current ratio 4.11
Quick ratio 4.11